How should I manage and educate an 18-year-old patient who developed a rash after 7 days of Augmentin (amoxicillin‑clavulanate) for preseptal cellulitis, and what alternative treatment should be given?

Management of Augmentin-Associated Rash After 7 Days of Treatment

Stop the Augmentin immediately and reassure the patient that this is likely a benign delayed hypersensitivity reaction, not a true penicillin allergy requiring future avoidance. For continued treatment of preseptal cellulitis, switch to an alternative beta-lactam such as cephalexin or clindamycin to complete the antibiotic course 1.

Immediate Assessment: Characterize the Rash

First, determine the rash type and severity:

• Benign delayed rash (most likely): Maculopapular, appears 7-10 days into treatment, non-pruritic or mildly itchy, no mucosal involvement, patient feels well
• Serum sickness-like reaction: Urticarial or maculopapular rash with fever, arthralgias, intense pruritus (especially hands/feet), typically 5-10 days after starting treatment 2
• Severe cutaneous reactions (rare but critical): Blistering, mucosal involvement (eyes, mouth, genitals), skin sloughing, systemic toxicity—these require immediate hospitalization 3

Key pitfall: The FDA label notes that "a high percentage of patients with mononucleosis who receive ampicillin develop an erythematous skin rash" 4. Ask about recent sore throat, fatigue, or lymphadenopathy that might suggest undiagnosed EBV infection 5.

Patient Education and Conversation

What to tell the patient:

"You've developed a rash from the Augmentin, which is common and usually not dangerous. This is likely a delayed reaction that happens in about 5-10% of people taking this antibiotic. This does NOT mean you're allergic to all penicillins or that you can never take them again. Most people with this type of rash can safely take penicillin antibiotics in the future" 6.

Explain the mechanism: The 2022 drug allergy practice parameter emphasizes that delayed rashes (appearing after 5-7 days) are typically T-cell mediated reactions, not IgE-mediated true allergies 6. Recent evidence shows that single-day challenges after negative testing can safely identify most patients who can tolerate penicillins, and that extended multi-day challenges are unnecessary since delayed reactions are typically mild 6.

Critical counseling point: Tell the patient to return immediately if they develop:

• Blistering or skin peeling
• Mouth sores or eye involvement
• Fever with worsening rash
• Difficulty breathing or swallowing

Treatment Plan

For the Rash:

• Mild maculopapular rash: Oral antihistamines (cetirizine 10 mg daily or diphenhydramine 25-50 mg every 6 hours) for symptomatic relief
• Serum sickness-like reaction: NSAIDs (ibuprofen 400-600 mg every 6-8 hours) are first-line; symptoms typically improve within 2-3 days 2
• Do NOT routinely prescribe corticosteroids for simple drug rashes—they are unnecessary and add side effects

For Continued Cellulitis Treatment:

The IDSA guidelines specify that preseptal cellulitis requires coverage for streptococci, and suitable alternatives include penicillin, cephalexin, dicloxacillin, or clindamycin 1.

Recommended antibiotic switch:

• First choice: Cephalexin 500 mg PO four times daily (or 25-50 mg/kg/day divided QID in pediatrics)
• Alternative: Clindamycin 300-450 mg PO three times daily (or 10-20 mg/kg/day divided TID in pediatrics)

Duration: Complete a total of 5-7 days of antibiotic therapy if clinical improvement has occurred 1. Since the patient has already received 7 days of Augmentin, assess the preseptal cellulitis clinically:

• If resolved or nearly resolved: No additional antibiotics needed
• If still active inflammation: Continue alternative antibiotic for 2-3 more days

MRSA coverage is NOT needed for typical preseptal cellulitis unless there is purulent drainage or penetrating trauma 1.

Documentation and Future Allergy Status

Critical documentation point: Do NOT label this patient as "penicillin allergic" in the medical record. Instead, document:

• "Delayed maculopapular rash to amoxicillin-clavulanate on day 7 of therapy"
• "Low-risk reaction—patient is candidate for future penicillin use with appropriate evaluation"

The 2022 practice parameter strongly recommends against routine penicillin skin testing for delayed reactions and states that most patients with delayed rashes can be safely rechallenged with penicillins in the future if needed 6. The evidence shows that resensitization after oral penicillin treatment is rare and comparable to the general population sensitization rate 6.

Follow-up

• Rash should resolve within 3-7 days after stopping Augmentin
• No routine follow-up needed if rash resolves and cellulitis improves
• If future penicillin needed: Patient can undergo direct oral challenge without preceding skin testing for this type of low-risk delayed reaction 6